Revance Therapeutics (RVNC) Earnings Date & Reports

Industry: @Pharmaceuticals Other

A.I. Advisor

published Earnings

RVNC is expected to report earnings to fall 7.69% to -33 cents per share on November 05

Revance Therapeutics RVNC Stock Earnings Reports

Q3'24

Est.

$-0.33

Q2'24

Est.

$-0.36

Q1'24

Missed

by $0.03

Q4'23

Beat

by $0.03

Q3'23

Missed

by $0.92

The last earnings report on August 08 showed earnings per share of -36 cents, meeting the estimate of -36 cents. With 1.03M shares outstanding, the current market capitalization sits at 558.41M.

View a ticker or compare two or three

Compare

RVNC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For RVNC
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RVNC (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of drugs

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

1222 Demonbreun Street

Phone

+1 615 724-7755

Employees

597

Web

https://www.revance.com